SIG — Sigma Healthcare Income Statement
0.000.00%
Last trade - 00:00- AU$34.85bn
- AU$36.77bn
- AU$4.93bn
- 72
- 16
- 82
- 61
Annual income statement for Sigma Healthcare, fiscal year end - January 31st, AUD millions except per share, conversion factor applied.
R2021 January 31st | C2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,509 | 3,549 | 3,762 | 3,417 | 4,926 |
| Cost of Revenue | |||||
| Gross Profit | 348 | 341 | 356 | 313 | 366 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3,469 | 3,547 | 3,743 | 3,394 | 4,904 |
| Operating Profit | 40 | 2.31 | 19.3 | 23.2 | 21.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 28.6 | -8.31 | 5.46 | 8.62 | 11.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 45 | -6.34 | 3.03 | 5.31 | -12.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 43.5 | -7.24 | 1.81 | 4.51 | -13.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 43.5 | -7.24 | 1.81 | 4.51 | -13.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.035 | -0.006 | 0.009 | 0.004 | 0.009 |
| Dividends per Share |